0000000001310705

AUTHOR

M. Ghazi

SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study

Abstract Background Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. Methods The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18–49, 50–69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty. Results NNVs were more favourable in su…

research product

Correction to: Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study (Intensive Care Medicine, (2016), 42, 12, (1865-1876), 10.1007/s00134-016-4571-5)

The members of the LUNG SAFE Investigators and the ESICM Trials Group were provided in such a way that they could not be indexed as collaborators on PubMed. The publisher apologizes for this error.

research product

Resolved versus confirmed ARDS after 24 h: insights from the LUNG SAFE study

Purpose: To evaluate patients with resolved versus confirmed ARDS, identify subgroups with substantial mortality risk, and to determine the utility of day 2 ARDS reclassification. Methods: Our primary objective, in this secondary LUNG SAFE analysis, was to compare outcome in patients with resolved versus confirmed ARDS after 24 h. Secondary objectives included identifying factors associated with ARDS persistence and mortality, and the utility of day 2 ARDS reclassification. Results: Of 2377 patients fulfilling the ARDS definition on the first day of ARDS (day 1) and receiving invasive mechanical ventilation, 503 (24%) no longer fulfilled the ARDS definition the next day, 52% of whom initial…

research product

CCDC 119191: Experimental Crystal Structure Determination

Related Article: E.Colacio, J.M.Dominguez-Vera, M.Ghazi, R.Kivekas, F.Lloret, J.M.Moreno, H.Stoeckli-Evans|1999|Chem.Commun.||987|doi:10.1039/a902041a

research product

CCDC 119192: Experimental Crystal Structure Determination

Related Article: E.Colacio, J.M.Dominguez-Vera, M.Ghazi, R.Kivekas, F.Lloret, J.M.Moreno, H.Stoeckli-Evans|1999|Chem.Commun.||987|doi:10.1039/a902041a

research product

CCDC 172232: Experimental Crystal Structure Determination

Related Article: E.Colacio, M.Ghazi, H.Stoeckli-Evans, F.Lloret, J.M.Moreno, C.Perez|2001|Inorg.Chem.|40|4876|doi:10.1021/ic0103446

research product

CCDC 172231: Experimental Crystal Structure Determination

Related Article: E.Colacio, M.Ghazi, H.Stoeckli-Evans, F.Lloret, J.M.Moreno, C.Perez|2001|Inorg.Chem.|40|4876|doi:10.1021/ic0103446

research product